Formulation of Vaccine Adjuvant Muramyldipeptides (MDP). 1. Characterization of Amorphous and Crystalline Forms of a Muramyldipeptide Analogue

This publication has 13 references indexed in Scilit:

• Synthesis and biological activities of N-acetyl-1-thiomuramoyl-l-alanyl-d-isoglutamine and some of its lipophilic derivatives
  Carbohydrate Research, 1983
• Syntheses and Immunoadjuvant Activity of Some Carbohydrate Analogs ofN-Acetylmuramyl-l-alanyl-d-isoglutamme
  Agricultural and Biological Chemistry, 1980
• The anomeric configuration of the immunostimulant N-acetylmuramoyl-dipeptide and some of its derivatives
  Carbohydrate Research, 1980
• Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
• Past, present and future of the synthetic immunoadjuvant MDP and its analogs
  Biochemical Pharmacology, 1978
• IMMUNOADJUVANT ACTIVITIES OF SYNTHETIC 6-O-ACYL-N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE WITH SPECIAL REFERENCE TO EFFECT OF ITS ADMINISTRATION WITH LIPOSOMES
  1977
• Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers
  Biochemical and Biophysical Research Communications, 1976
• Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives
  Biochemical and Biophysical Research Communications, 1975
• Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
  1975
• Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives
  Biochemical and Biophysical Research Communications, 1974